Literature DB >> 19439424

Targeted loss of Arx results in a developmental epilepsy mouse model and recapitulates the human phenotype in heterozygous females.

Eric Marsh1, Carl Fulp, Ernest Gomez, Ilya Nasrallah, Jeremy Minarcik, Jyotsna Sudi, Susan L Christian, Grazia Mancini, Patricia Labosky, William Dobyns, Amy Brooks-Kayal, Jeffrey A Golden.   

Abstract

Mutations in the X-linked aristaless-related homeobox gene (ARX) have been linked to structural brain anomalies as well as multiple neurocognitive deficits. The generation of Arx-deficient mice revealed several morphological anomalies, resembling those observed in patients and an interneuron migration defect but perinatal lethality precluded analyses of later phenotypes. Interestingly, many of the neurological phenotypes observed in patients with various ARX mutations can be attributed, in part, to interneuron dysfunction. To directly test this possibility, mice carrying a floxed Arx allele were generated and crossed to Dlx5/6(CRE-IRES-GFP)(Dlx5/6(CIG)) mice, conditionally deleting Arx from ganglionic eminence derived neurons including cortical interneurons. We now report that Arx(-/y);Dlx5/6(CIG) (male) mice exhibit a variety of seizure types beginning in early-life, including seizures that behaviourally and electroencephalographically resembles infantile spasms, and show evolution through development. Thus, this represents a new genetic model of a malignant form of paediatric epilepsy, with some characteristics resembling infantile spasms, caused by mutations in a known infantile spasms gene. Unexpectedly, approximately half of the female mice carrying a single mutant Arx allele (Arx(-/+);Dlx5/6(CIG)) also developed seizures. We also found that a subset of human female carriers have seizures and neurocognitive deficits. In summary, we have identified a previously unrecognized patient population with neurological deficits attributed to ARX mutations that are recapitulated in our mouse model. Furthermore, we show that perturbation of interneuron subpopulations is an important mechanism underling the pathogenesis of developmental epilepsy in both hemizygous males and carrier females. Given the frequency of ARX mutations in patients with infantile spasms and related disorders, our data unveil a new model for further understanding the pathogenesis of these disorders.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19439424      PMCID: PMC2685924          DOI: 10.1093/brain/awp107

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  42 in total

1.  ARX, a novel Prd-class-homeobox gene highly expressed in the telencephalon, is mutated in X-linked mental retardation.

Authors:  Thierry Bienvenu; Karine Poirier; Gaelle Friocourt; Nadia Bahi; Delphine Beaumont; Fabien Fauchereau; Lamia Ben Jeema; Ramzi Zemni; Marie-Claude Vinet; Fiona Francis; Philippe Couvert; Marie Gomot; Claude Moraine; Hans van Bokhoven; Vera Kalscheuer; Suzanne Frints; Josef Gecz; Kanae Ohzaki; Habiba Chaabouni; Jean-Pierre Fryns; Vincent Desportes; Cherif Beldjord; Jamel Chelly
Journal:  Hum Mol Genet       Date:  2002-04-15       Impact factor: 6.150

2.  X-linked lissencephaly with absent corpus callosum and ambiguous genitalia (XLAG): clinical, magnetic resonance imaging, and neuropathological findings.

Authors:  Dominique Bonneau; Annick Toutain; Annie Laquerrière; Stéphane Marret; Pascale Saugier-Veber; Marie-Anne Barthez; Sophie Radi; Valérie Biran-Mucignat; Diana Rodriguez; Antoinette Gélot
Journal:  Ann Neurol       Date:  2002-03       Impact factor: 10.422

3.  Mutation of ARX causes abnormal development of forebrain and testes in mice and X-linked lissencephaly with abnormal genitalia in humans.

Authors:  Kunio Kitamura; Masako Yanazawa; Noriyuki Sugiyama; Hirohito Miura; Akiko Iizuka-Kogo; Masatomo Kusaka; Kayo Omichi; Rika Suzuki; Yuko Kato-Fukui; Kyoko Kamiirisa; Mina Matsuo; Shin-ichi Kamijo; Megumi Kasahara; Hidefumi Yoshioka; Tsutomu Ogata; Takayuki Fukuda; Ikuko Kondo; Mitsuhiro Kato; William B Dobyns; Minesuke Yokoyama; Ken-ichirou Morohashi
Journal:  Nat Genet       Date:  2002-10-15       Impact factor: 38.330

Review 4.  Infantile spasms: criteria for an animal model.

Authors:  Carl E Stafstrom; Gregory L Holmes
Journal:  Int Rev Neurobiol       Date:  2002       Impact factor: 3.230

Review 5.  How do the many etiologies of West syndrome lead to excitability and seizures? The corticotropin releasing hormone excess hypothesis.

Authors:  K L Brunson; M Eghbal-Ahmadi; T Z Baram
Journal:  Brain Dev       Date:  2001-11       Impact factor: 1.961

6.  X-inactivation patch size in human female tissue confounds the assessment of tumor clonality.

Authors:  Marco Novelli; Antonio Cossu; Dahmane Oukrif; Alberto Quaglia; Sunil Lakhani; Richard Poulsom; Peter Sasieni; Piera Carta; Marcella Contini; Anna Pasca; Giuseppe Palmieri; Walter Bodmer; Francesco Tanda; Nick Wright
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-27       Impact factor: 11.205

7.  X-linked myoclonic epilepsy with spasticity and intellectual disability: mutation in the homeobox gene ARX.

Authors:  Ingrid E Scheffer; R H Wallace; F L Phillips; P Hewson; K Reardon; G Parasivam; P Stromme; S F Berkovic; J Gecz; J C Mulley
Journal:  Neurology       Date:  2002-08-13       Impact factor: 9.910

8.  Opposing actions of Arx and Pax4 in endocrine pancreas development.

Authors:  Patrick Collombat; Ahmed Mansouri; Jacob Hecksher-Sorensen; Palle Serup; Jens Krull; Gerard Gradwohl; Peter Gruss
Journal:  Genes Dev       Date:  2003-10-15       Impact factor: 11.361

9.  Balanced X chromosome inactivation patterns in the Rett syndrome brain.

Authors:  Mona D Shahbazian; Yaling Sun; Huda Y Zoghbi
Journal:  Am J Med Genet       Date:  2002-08-01

Review 10.  Stressed-out, or in (utero)?

Authors:  Sarit Avishai-Eliner; Kristen L Brunson; Curt A Sandman; Tallie Z Baram
Journal:  Trends Neurosci       Date:  2002-10       Impact factor: 13.837

View more
  85 in total

1.  Nkx2.2 repressor complex regulates islet β-cell specification and prevents β-to-α-cell reprogramming.

Authors:  James B Papizan; Ruth A Singer; Shuen-Ing Tschen; Sangeeta Dhawan; Jessica M Friel; Susan B Hipkens; Mark A Magnuson; Anil Bhushan; Lori Sussel
Journal:  Genes Dev       Date:  2011-11-01       Impact factor: 11.361

Review 2.  The Rhox genes.

Authors:  James A MacLean; Miles F Wilkinson
Journal:  Reproduction       Date:  2010-04-29       Impact factor: 3.906

Review 3.  Excitatory/Inhibitory Balance and Circuit Homeostasis in Autism Spectrum Disorders.

Authors:  Sacha B Nelson; Vera Valakh
Journal:  Neuron       Date:  2015-08-19       Impact factor: 17.173

4.  In search of epilepsy biomarkers in the immature brain: goals, challenges and strategies.

Authors:  Aristea S Galanopoulou; Solomon L Moshé
Journal:  Biomark Med       Date:  2011-10       Impact factor: 2.851

Review 5.  West Syndrome: A Review and Guide for Paediatricians.

Authors:  Renato D'Alonzo; Donato Rigante; Elisabetta Mencaroni; Susanna Esposito
Journal:  Clin Drug Investig       Date:  2018-02       Impact factor: 2.859

Review 6.  Epilepsy genetics--past, present, and future.

Authors:  Annapurna Poduri; Daniel Lowenstein
Journal:  Curr Opin Genet Dev       Date:  2011-01-27       Impact factor: 5.578

7.  Deletion of Dlx1 results in reduced glutamatergic input to hippocampal interneurons.

Authors:  Daniel L Jones; MacKenzie A Howard; Amelia Stanco; John L R Rubenstein; Scott C Baraban
Journal:  J Neurophysiol       Date:  2011-02-16       Impact factor: 2.714

8.  Westward ho! Pioneering mouse models for x-linked infantile spasms syndrome.

Authors:  Janice R Naegele
Journal:  Epilepsy Curr       Date:  2010-01       Impact factor: 7.500

Review 9.  Genetic animal models of malformations of cortical development and epilepsy.

Authors:  Michael Wong; Steven N Roper
Journal:  J Neurosci Methods       Date:  2015-04-21       Impact factor: 2.390

10.  CDKL5 and ARX mutations in males with early-onset epilepsy.

Authors:  Ghayda M Mirzaa; Alex R Paciorkowski; Eric D Marsh; Elizabeth M Berry-Kravis; Livija Medne; Asem Alkhateeb; Art Grix; Elaine C Wirrell; Berkley R Powell; Katherine C Nickels; Barbara Burton; Andrea Paras; Katherine Kim; Wendy Chung; William B Dobyns; Soma Das
Journal:  Pediatr Neurol       Date:  2013-05       Impact factor: 3.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.